You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

TORSEMIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for torsemide and what is the scope of freedom to operate?

Torsemide is the generic ingredient in three branded drugs marketed by Roche, Am Regent, West-ward Pharms Int, Norvium Bioscience, Sarfe Pharms, Aurobindo Pharma, Heritage, Hetero Labs Ltd Iii, Hikma, Pliva Pharm Ind, Strides Pharma, Sun Pharm Inds, and Teva, and is included in fourteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Torsemide has two patent family members in two countries.

There are sixteen drug master file entries for torsemide. Twenty-one suppliers are listed for this compound.

Drug Prices for TORSEMIDE

See drug prices for TORSEMIDE

Drug Sales Revenue Trends for TORSEMIDE

See drug sales revenues for TORSEMIDE

Recent Clinical Trials for TORSEMIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sarfez Pharmaceuticals, Inc.Phase 2
Assiut UniversityPhase 4
National Heart, Lung, and Blood Institute (NHLBI)Phase 3

See all TORSEMIDE clinical trials

Pharmacology for TORSEMIDE
Drug ClassLoop Diuretic
Physiological EffectIncreased Diuresis at Loop of Henle

US Patents and Regulatory Information for TORSEMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strides Pharma TORSEMIDE torsemide TABLET;ORAL 076226-003 May 27, 2003 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva TORSEMIDE torsemide TABLET;ORAL 076110-004 May 14, 2002 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hetero Labs Ltd Iii TORSEMIDE torsemide TABLET;ORAL 079234-003 Jan 27, 2009 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TORSEMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Norvium Bioscience DEMADEX torsemide TABLET;ORAL 020136-002 Aug 23, 1993 ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience DEMADEX torsemide TABLET;ORAL 020136-004 Aug 23, 1993 ⤷  Sign Up ⤷  Sign Up
Norvium Bioscience DEMADEX torsemide TABLET;ORAL 020136-004 Aug 23, 1993 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for TORSEMIDE

Country Patent Number Title Estimated Expiration
European Patent Office 3065718 FORMULATIONS À LIBÉRATION CONTRÔLÉE COMPRENANT DU TORSÉMIDE (CONTROLLED-RELEASE FORMULATIONS COMPRISING TORSEMIDE) ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2015050570 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.